[ad_1]
Dublin, January 31, 2019 (GLOBE NEWSWIRE) – The Breast Imaging market by technology (ionization (mammography (digital mammography, 3D mammography, badog), MBI, PET-CT, PEM), non-ionizing (Ultrasound Breast MRI, Automated Whole Breast Ultrasound, Breast Thermography) – "Global Forecasts to 2023" report has been added to ResearchAndMarkets.com & # 39; s offer.
The global bad imaging market is valued at $ 3,117.3 million in 2018 and is expected to grow at a compound annual growth rate of 8.0% over the forecast period.
Breast imaging is the use of various technologies for the screening and diagnosis of bad cancer and other bad-related diseases. These include ionizing and non-ionizing bad imaging technologies.
The growth in this market is mainly due to the growing prevalence of bad cancer in women, technological advances in bad imaging modalities, increasing government investments in bad cancer treatment and the development of bad cancer. related research, increased awareness of early detection of bad cancer and growth in the aging population.
The bad imaging market is diverse and competitive, with a large number of players dominating different product segments based on key skills. In 2017, Hologic, Inc. (United States), GE Healthcare (United States), Siemens Healthineers (Germany) and Philips Healthcare (Netherlands) were the leading companies in the market.
Key topics covered:
1. Introduction
2 Research Methodology
3 Summary
4 Premium Insights
4.1 Breast Imaging: Market Overview
4.2 Technology Analysis – Breast Imaging Market, by Region
4.3 Mammography Market in Asia-Pacific by Type and Country
4.4 European ionizing bad imaging market, by type and country
4.5 Non-ionizing bad imaging market, by type
4.6 Geographic Overview of the Breast Imaging Market
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing incidence of bad cancer
5.2.1.2 Increase in investments, funds and public-private subsidies
5.2.1.3 Increased awareness of early detection of bad cancer
5.2.1.4 Growth of the aging population
5.2.2 Restraint
5.2.2.1 High cost of bad imaging systems
5.2.2.2 Unfavorable repayment scenario
5.2.3 Opportunities
5.2.3.1 Emerging economies offer strong growth potential
5.2.3.2 Miniaturization and technological progress
5.2.4 Challenges
5.2.4.1 Side Effects of Radiation Exposure
5.2.4.2 Errors in Breast Cancer Screening and Diagnosis
5.2.4.3 Risk of overdiagnosis and anxiety of the patient
5.2.4.4 Increasing Adoption of Refurbished Imaging Systems
5.3 Market Trends
5.3.1 Artificial intelligence
5.3.2 Personalized approach to bad cancer screening
5.4 Guidelines for Breast Cancer Screening
5.5 Price Analysis
6 Breast imaging market, by technology
6.1 Introduction
6.2 Ionizing Breast Imaging Technologies
6.2.1 Mammography
6.2.1.1 Full Field Digital Mammography
6.2.1.1.1 Ffdm offers significant advantages over conventional badogue mammography, such as the use of lower radiation doses and reduced bad compression pressure
6.2.1.2 Analog Mammography
6.2.1.2.1 Superior accuracy and efficiency offered by digital mammography systems limit the adoption of the badog mammography system
6.2.1.3 Breast tomosynthesis in 3D
6.2.1.3.1 The 3D bad tomosynthesis segment will demonstrate the highest growth rate in the mammography market over the forecast period
6.2.2 Positron Emission Tomography – Computerized Tomography (Pet-Ct)
6.2.2.1 The combined badyzes of the animal and the patient provide a more accurate diagnosis than the individual badyzes carried out.
6.2.3 Molecular imaging of the bad
6.2.3.1 The Mbi technique is simple, fast and extremely sensitive. It can be used for patients who are claustrophobic or allergic to gadolinium.
6.2.4 Positron emission mammography
6.2.4.1 MEP involves exposure to radiation throughout the body, which increases the risk of cancer. A major disadvantage badociated with this technique
6.3 Non-ionizing mammary imaging technologies
6.3.1 Breast ultrasound
6.3.1.1 Cost reduction, increasing awareness and easy availability of ultrasound devices for bad imaging are driving growth in this market
6.3.2 MRI of the bad
6.3.2.1 Technological advances in bad MRI and the increasing demand for technologies that use minimal radiation use are key factors in the growth of this market
6.3.3 Automated whole-bad ultrasonography
6.3.3.1 Awbu helps detect tiny cancers in bad mammograms
6.3.4 Breast thermography
6.3.4.1 This technique is not effective when used as a stand-alone test for bad cancer screening
6.4 Other bad imaging technologies
6.4.1 Optical imaging
6.4.2 Cone beam computer tomography
6.4.3 Electrical impedance tomography
6.5 Software of cad
7 bad imaging market, by region
7.1 Introduction
7.2 North America
7.2.1 US
7.2.1.1 The United States will dominate the North American bad imaging market
7.2.2 Canada
7.2.2.1 Increasing Incidence of Breast Cancer and Government Breast Cancer Awareness Initiatives to Boost Market Growth in Canada
7.3 Europe
7.3.1 Germany
7.3.1.1 Broader acceptance of ionizing and non-ionizing bad imaging technologies and the increasing demand for improved diagnostics are the main drivers of market growth in Germany
7.3.2 France
7.3.2.1 The rapid aging of the population and the high incidence of bad cancer are at the origin of the adoption of bad imaging technologies in France
7.3.3 UK
7.3.3.1 High rate of bad cancer incidence and public and private initiatives to raise awareness of early detection and detection of bad cancer to stimulate market growth
7.3.4 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.1.1 Growing Geriatric Population and Presence of a Universal Health Care Reimbursement Scenario to Promote the Adoption of Breast Imaging Procedures in Japan
7.4.2 China
7.4.2.1 Increasing incidence of bad cancer and increase in the number of patients in China to stimulate the demand for bad imaging in the country
7.4.3 India
7.4.3.1 Government initiatives to improve women's health to stimulate market growth in India
7.4.4 Rest of the ICCA
7.5 Rest of the world
7.5.1 Latin America
7.5.1.1 Latin America will represent the largest share of the bad imaging market in the RoW in 2018
7.5.2 Middle East and Africa
7.5.2.1 Improving health care infrastructure and increasing public-private investment to stimulate market growth in the Me & A region
8 competitive landscape
8.1 Introduction
8.2 Competitive Leadership Mapping (Global Market)
8.3 Criteria for inclusion of suppliers
8.4 Diving the seller
8.5 Competitive Leadership Mapping (Smse / Start-Up)
8.6 Analysis of market shares, by category
8.7 Competitive Scenario
9 company profiles
- Aurora, Inc. Imaging Technology
- Canon Inc.
- Cmr Naviscan
- Delphinus Medical Technologies, Inc.
- Dilon Technologies, Inc.
- Fujifilm Holdings Corporation
- GE Healthcare (part of General Electric Company)
- Hologic, Inc.
- Kub Technologies
- Micrima Limited
- Philips Healthcare (part of Koninklijke Philips N.V.)
- Planmed Oy
- Siemens Healthineers (part of Siemens AG)
- Sonocin, Inc.
- Supersonic Imagine
For more information on this report, visit https://www.researchandmarkets.com/research/zhr586/3_11_billion?w=12
Research and Markets also offers customized research services that provide targeted, comprehensive and personalized research.
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Secretary [email protected] For office hours, call 1-917-300-0470 For toll-free calls to the United States and Canada: 1-800-526-8630 For GMT office hours, call + 353-1-416-8900 Related topics: Mammography
Source link
